Changes in plasma mullerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women

被引：6

作者：

Aslam, Muhammad Faisal ^{[1
]}

Merhi, Zaher O. ^{[2
]}

Ahmed, Safaa ^{[1
]}

Kuzbari, Oumar ^{[1
]}

Seifer, David B. ^{[1
]}

Minkoff, Howard ^{[1
]}

机构：

[1] Maimonides Hosp, Dept Obstet & Gynecol, Brooklyn, NY 11219 USA

[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Bronx, NY 10467 USA

来源：

FERTILITY AND STERILITY | 2011年 / 95卷 / 05期

关键词：

Anti-mullerian hormone; brain-derived neurotrophic factor; cancer; chemotherapy; mullerian-inhibiting substance; ovarian reserve; ASSISTED REPRODUCTIVE TECHNOLOGY; CHILDHOOD-CANCER SURVIVORS; OVARIAN RESERVE; BREAST-CANCER; FOLLICULAR-FLUID; MENSTRUAL CYCLES; HUMAN PLATELETS; NERVOUS-SYSTEM; HORMONE; EXPRESSION;

D O I：

10.1016/j.fertnstert.2010.10.033

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and mullerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy. (Fertil Steril (R) 2011; 95: 1790-3. (C) 2011 by American Society for Reproductive Medicine.)

引用

页码：1790 / 1793

页数：4

共 29 条

[1] The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer
Anderson, R. A.
Themmen, A. P. N.
Al-Qahtani, A.
Groome, N. P.
Cameron, D. A.
[J]. HUMAN REPRODUCTION, 2006, 21 (10) : 2583 - 2592
[2] ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH
BAARENDS, WM
UILENBROEK, JTJ
KRAMER, P
HOOGERBRUGGE, JW
VANLEEUWEN, ECM
THEMMEN, APN
GROOTEGOED, JA
[J]. ENDOCRINOLOGY, 1995, 136 (11) : 4951 - 4962
[3] Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound
Bath, LE
Wallace, WHB
Shaw, MP
Fitzpatrick, C
Anderson, RA
[J]. HUMAN REPRODUCTION, 2003, 18 (11) : 2368 - 2374
[4] Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor
Begliuomini, S.
Casarosa, E.
Pluchino, N.
Lenzi, E.
Centofanti, M.
Freschi, L.
Pieri, M.
Genazzani, A. D.
Luisi, S.
Genazzani, Andrea R.
[J]. HUMAN REPRODUCTION, 2007, 22 (04) : 995 - 1002
[5] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
Bines, J
Oleske, DM
Cobleigh, MA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1718 - 1729
[6] Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility
Buyuk, Erkan
Seifer, David B.
[J]. FERTILITY AND STERILITY, 2008, 90 (05) : 1611 - 1615
[7] Antimullerian hormone serum levels: a putative marker for ovarian aging
de Vet, A
Laven, JSE
de Jong, FH
Themmen, APN
Fauser, BCJM
[J]. FERTILITY AND STERILITY, 2002, 77 (02) : 357 - 362
[8] Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
Decanter, Christine
Morschhauser, Franck
Pigny, Pascal
Lefebvre, Catherine
Gallo, Cecile
Dewailly, Didier
[J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2010, 20 (02) : 280 - 285
[9] Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
Fong, S. Lie
Laven, J. S. E.
Hakvoort-Cammel, F. G. A. J.
Schipper, I.
Visser, J. A.
Themmen, A. P. N.
de Jong, F. H.
van den Heuvel-Eibrink, M. M.
[J]. HUMAN REPRODUCTION, 2009, 24 (04) : 982 - 990
[10] Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/I
Larsen, EC
Müller, J
Rechnitzer, C
Schmiegelow, K
Andersen, AN
[J]. HUMAN REPRODUCTION, 2003, 18 (02) : 417 - 422

← 1 2 3 →